On Demand: Closing the Gap: Post-TAVR and TTVR Monitoring as a Clinical and Operational Imperative-Webinar Recording

Video Transcription

Video Summary

The webinar focused on reducing conduction-related harm after transcatheter aortic valve replacement (TAVR) and transcatheter tricuspid valve procedures, while supporting safe, efficient patient discharge.<br /><br />Panelists emphasized assessing pacemaker risk before TAVR and discussing it openly with patients. Risk factors and procedural changes—such as pre-existing right bundle branch block, new left bundle branch block, PR prolongation, or conduction disturbances during the procedure—can guide decisions about monitoring and follow-up. Practices varied, but many participants favored about 14 days of monitoring after higher-risk TAVR; tricuspid valve patients may warrant longer, often 30-day, monitoring because risks and best practices remain uncertain.<br /><br />A central recommendation was to involve electrophysiology early and build a coordinated workflow with structural cardiology, nursing, administration, and other relevant teams. Panelists stressed that real-time mobile cardiac telemetry is preferable for high-risk patients to monitors that only provide data after they are returned, since timely alerts can allow intervention before a serious event. Clear protocols, backup communication pathways, EHR integration, and shared responsibility help prevent missed alerts and support safe early discharge.<br /><br />The discussion also highlighted operational and financial considerations, including readmissions, pacemaker-related costs, reporting, and legal risk. For new programs—especially tricuspid interventions—teams should proceed cautiously, standardize monitoring and escalation plans, and ensure broad stakeholder buy-in.

Keywords

TAVR

transcatheter tricuspid valve procedures

conduction-related harm

pacemaker risk

right bundle branch block

left bundle branch block

PR prolongation

mobile cardiac telemetry

electrophysiology

patient discharge